BriaCell Therapeutics

/BriaCell Therapeutics

Follow-on

BriaCell Therapeutics

Biotechnology

Follow-on/Uplisting: BriaCell is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer, with a focus on advanced breast cancer.

Symbol

BCTX

Last Closing Price
$5.34

Shares
5,882,353

Anticipated Date
February 24, 2021

Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.

This offering is no longer available

To view the prospectus for BriaCell Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange